Could it be time to consider buying CSL shares?
A number of Australia’s leading brokers have given their verdict on the CSL share price in recent months. And as you might expect due to COVID-19 uncertainties, opinion is largely divided on whether now is a good time to consider buying CSL shares.
Below is a summary of what brokers are saying about CSL shares in July 2021.
Citi
Citi currently has a neutral rating and $310.00 CSL share price target. This implies potential upside of 11% over the next 12 months. Citi is also forecasting a CSL dividend of $3.14 per share in FY 2021.
Goldman Sachs
Goldman Sachs has a neutral rating and CSL share price target of $305.00. If CSL shares hit this level, it will mean a gain of 9.2%. In addition, Goldman has pencilled in a CSL dividend of $2.81 this year.
Morgans
Morgans currently has an add rating and CSL share price target of $301.10. This represents a potential return of 7.9%. The broker is also forecasting a CSL dividend of $2.86 per share in FY 2021.
UBS
UBS is the most bullish broker with a buy rating and CSL share price target of $330.00. This implies potential upside of 18.2% over the next 12 months. UBS’ analysts are forecasting a CSL dividend of ~$2.33 per share in 2021.
Broker comments
The team at Goldman Sachs explained why they are neutral on the CSL share price.
Goldman said: “We are Neutral rated on CSL. Our 12-month TP of A$305 is based on our target NTM EV/EBITDA multiple of 28.9x. Key upside risks include: (1) Faster-than-expected recovery in plasma collections; (2) More supportive pricing dynamic than we already expect; (3) Positive results from the pipeline. Key downside risks include: (1) Extent of disruption to plasma collections; (2) Threat of mRNA/competitive approaches to Seqirus vaccine business; (3) Competitive product launches; (4) Plasma donor fee inflation.”
- Forums
- ASX - By Stock
- CSL
- Could it be time to consider buying CSL shares ?
Could it be time to consider buying CSL shares ?
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$287.92 |
Change
1.570(0.55%) |
Mkt cap ! $139.1B |
Open | High | Low | Value | Volume |
$287.99 | $289.76 | $286.98 | $184.0M | 638.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5 | $286.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$288.00 | 260 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 286.400 |
1 | 75 | 286.040 |
1 | 650 | 286.030 |
1 | 3 | 286.000 |
1 | 5 | 285.500 |
Price($) | Vol. | No. |
---|---|---|
288.000 | 260 | 2 |
288.280 | 32 | 1 |
288.650 | 10 | 1 |
288.830 | 100 | 1 |
288.880 | 410 | 1 |
Last trade - 16.10pm 29/03/2024 (20 minute delay) ? |
|
|||||
Last
$288.43 |
  |
Change
1.570 ( 0.76 %) |
|||
Open | High | Low | Volume | ||
$287.84 | $289.73 | $286.99 | 117701 | ||
Last updated 15.59pm 29/03/2024 ? |
Featured News
CSL (ASX) Chart |